Robert F. Kennedy Jr. Cancels $500 Million in mRNA Vaccine Projects, Including for COVID and Flu
PorAinvest
miércoles, 6 de agosto de 2025, 9:20 am ET1 min de lectura
MRNA--
Kennedy, a long-time vaccine skeptic, cited the failure of mRNA vaccines to effectively protect against upper respiratory infections and their susceptibility to viral mutations as reasons for the cancellation. He stated that the department would shift its focus to "safer, broader vaccine strategies, like whole-virus vaccines and novel platforms that don't collapse when viruses mutate" [1].
The move has sparked shock among health experts and pharmaceutical companies, which rely on government support for vaccine research and development. Dr. Vinay Prasad, the FDA's top vaccine official, had previously limited the approval of the COVID-19 vaccine by Moderna and Novavax Inc. (NVAX) to higher-risk individuals, further highlighting the concerns surrounding mRNA vaccines [2].
Kennedy's decision signals a broader shift in federal vaccine development priorities. The Biomedical Advanced Research and Development Authority (BARDA) will now focus on platforms with stronger safety records and transparent clinical and manufacturing data practices. Technologies that failed to meet current scientific standards will be phased out in favor of evidence-based, ethically grounded solutions [3].
The cancellation of these projects has significant implications for the vaccine industry and the country's pandemic preparedness. Vaccine experts have expressed concern that this move will leave the United States vulnerable to future public health emergencies [3].
References:
[1] https://www.benzinga.com/news/health-care/25/08/46888794/rfk-jr-halts-500-million-in-mrna-vaccine-projects-backed-by-pfizer-moderna-were-prioritizing-safer-broader-strategies
[2] https://www.hhs.gov/press-room/hhs-winds-down-mrna-development-under-barda.html
[3] https://www.statnews.com/2025/08/05/mrna-vaccine-development-canceled-by-kennedy-hhs/
NVAX--
PFE--
US Health Secretary Robert F. Kennedy Jr. has cancelled 22 mRNA vaccine projects worth $500 million, funded by the Department of Health and Human Services. The projects targeted COVID-19, influenza, and bird flu. Kennedy believes mRNA vaccines are "troubled" and fail when viruses mutate, and plans to focus on safer and more durable vaccine types instead. The move has shocked health experts and Big Pharma, who depend on government support for vaccine research and development.
US Health Secretary Robert F. Kennedy Jr. has announced the cancellation of 22 mRNA vaccine projects worth $500 million, funded by the Department of Health and Human Services (HHS). The projects, aimed at combating COVID-19, influenza, and bird flu, were led by major pharmaceutical companies such as Pfizer Inc. (PFE) and Moderna Inc. (MRNA) [1].Kennedy, a long-time vaccine skeptic, cited the failure of mRNA vaccines to effectively protect against upper respiratory infections and their susceptibility to viral mutations as reasons for the cancellation. He stated that the department would shift its focus to "safer, broader vaccine strategies, like whole-virus vaccines and novel platforms that don't collapse when viruses mutate" [1].
The move has sparked shock among health experts and pharmaceutical companies, which rely on government support for vaccine research and development. Dr. Vinay Prasad, the FDA's top vaccine official, had previously limited the approval of the COVID-19 vaccine by Moderna and Novavax Inc. (NVAX) to higher-risk individuals, further highlighting the concerns surrounding mRNA vaccines [2].
Kennedy's decision signals a broader shift in federal vaccine development priorities. The Biomedical Advanced Research and Development Authority (BARDA) will now focus on platforms with stronger safety records and transparent clinical and manufacturing data practices. Technologies that failed to meet current scientific standards will be phased out in favor of evidence-based, ethically grounded solutions [3].
The cancellation of these projects has significant implications for the vaccine industry and the country's pandemic preparedness. Vaccine experts have expressed concern that this move will leave the United States vulnerable to future public health emergencies [3].
References:
[1] https://www.benzinga.com/news/health-care/25/08/46888794/rfk-jr-halts-500-million-in-mrna-vaccine-projects-backed-by-pfizer-moderna-were-prioritizing-safer-broader-strategies
[2] https://www.hhs.gov/press-room/hhs-winds-down-mrna-development-under-barda.html
[3] https://www.statnews.com/2025/08/05/mrna-vaccine-development-canceled-by-kennedy-hhs/
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios